Additionally, the study’s experimental results indicated that roflumilast could decrease the expression of KIM1 and NGAL, which were raised in sepsis-induced AKI, implying that roflumilast acted as a protective factor for kidney function. Here, HAVCR1 is linked to acute kidney injury.